Abstract:Background: Identification of the etiology, molecular mechanisms, and carcinogenic pathways of tongue squamous cell carcinoma (TSCC) is crucial for developing new diagnostic and therapeutic strategies. This study used bioinformatics methods to identify key genes in TSCC and explored the potential functions and pathway mechanisms related to the malignant biological behavior of TSCC. Methods: Gene chip data sets (i.e., GSE13601 and GSE34106) containing the data of both TSCC patients and normal control subjects were selected from the Gene Expression Omnibus (GEO) database. Using a gene expression analysis tool (GEO2R) of the GEO database, the differentially expressed genes (DEGs) were identified using the following criteria: |log fold change| >1, and P<0.05. The GEO2R tool was also used to select the upregulated DEGs in the chip candidates based on a P value <0.05. A Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, Gene Ontology (GO) function analysis, and a protein-protein interaction (PPI) network analysis were then conducted. The results were displayed using R language packages, including volcano plots, Venn diagrams, heatmaps, and enriched pathway bubble charts. Genes from the MalaCards database were compared with the candidate genes, and a thorough review of the literature was conducted to determine the clinical significance of these genes. Finally, feature gene-directed chemical drugs or targeted drugs were predicted using the Comparative Toxicogenomics Database (CTD). Results: In total, 767 upregulated DEGs were identified from GSE13601 and 695 from GSE34106. By intersecting the upregulated DEGs from both data sets using a Venn diagram, 100 DEGs related to TSCC were identified. The enrichment analysis of the KEGG signaling pathways identified the majority of the pathways associated with the upregulated DEGs, including the Toll-like receptor signaling pathway, the extracellular matrix-receptor interaction, the tumor necrosis factor (TNF) signaling pathway, cytokine-cytokine receptor interaction, the chemokine signaling pathway, the interlukin-17 signaling pathway, and natural killer cell-mediated cytotoxicity. The PPI network and module analyses of the shared DEGs ultimately resulted in five clusters and 55 candidate genes. A further intersection analysis of the TSCC-related genes in the MalaCards database via a Venn diagram identified three important shared DEGs; that is, matrix metalloproteinase-1 (MMP1), MMP9, and MMP13. In the CTD, seven drugs related to MMP13 were identified for treating tongue tumors. Conclusions: This study identified key genes and signaling pathways involved in TSCC and thus extended understandings of the molecular mechanisms that underlie the development and progression of TSCC. Additionally, this study showed that MMP13 may influence the malignant biological behavior of TSCC through the TNF signaling pathway. This finding could provide a theoretical basis for research into early differential diagnosis and targeted treatment.

Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma

Immunoexpression of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in the Metastasis of Squamous Cell Carcinoma of the Human Tongue

KLF7 is Associated with Poor Prognosis and Regulates Migration and Adhesion in Tongue Cancer

MMP7, Regulated by c-Jun, is Involved in Oral Squamous Cell Carcinoma and Associated with Cancer-Related Fibroblasts Infiltration

MMP-9 Knockdown Inhibits Oral Squamous Cell Carcinoma Lymph Node Metastasis in the Nude Mouse Tongue-Xenografted Model through the RhoC/Src Pathway

Exploring the effects of matrix metalloproteinase-13 on the malignant biological behavior of tongue squamous cell carcinoma via the TNF signaling pathway based on bioinformatics methods

Knockdown of LRP5 Promotes Proliferation and Invasion of Tongue Squamous Cell Carcinoma Through Compensatory Activation of Akt Signaling

Mir-34A Inhibits Migration and Invasion of Tongue Squamous Cell Carcinoma Via Targeting MMP9 and MMP14.

CXC chemokine‑7 inhibits growth and migration of oral tongue squamous cell carcinoma cells, mediated by the epithelial‑mesenchymal transition signaling pathway.

CCR7-CCL21 Axis Promotes the Cervical Lymph Node Metastasis of Tongue Squamous Cell Carcinoma by Up-Regulating MUC1

TGFβ1‐Smad3‐Jagged1‐Notch1–Slug Signaling Pathway Takes Part in Tumorigenesis and Progress of Tongue Squamous Cell Carcinoma

LncRNA MALAT1 Expression Inhibition Suppresses Tongue Squamous Cell Carcinoma Proliferation, Migration and Invasion by Inactivating PI3K/Akt Pathway and Downregulating MMP-9 Expression.

MMP1 Overexpression Promotes Cancer Progression and Associates with Poor Outcome in Head and Neck Carcinoma

Ptk7 is A Molecular Marker for Metastasis, Tnm Stage, and Prognosis in Oral Tongue Squamous Cell Carcinoma

Downregulation of MACC 1 Inhibits Invasion , Migration and Proliferation , Attenuates Cisplatin Resistance and Induces Apoptosis in Tongue Squamous Cell Carcinoma

7SK Acts as an Anti-tumor Factor in Tongue Squamous Cell Carcinoma

Overexpression of metabolic markers PKM2 and LDH5 correlates with aggressive clinicopathological features and adverse patient prognosis in tongue cancer

MTA3-SOX2 Module Regulates Cancer Stemness and Contributes to Clinical Outcomes of Tongue Carcinoma

Overexpression of HMGA2 Promotes Tongue Cancer Metastasis Through EMT Pathway

Expression of Matrix Metalloproteinase-7 Involving in Growth, Invasion, Metastasis and Angiogenesis of Gastric Cancer.

Semaphorin-7A Contributes to Growth, Migration and Invasion of Oral Tongue Squamous Cell Carcinoma Through TGF-β-mediated EMT Signaling Pathway.